How To Manage and Minimize GLP-1 Side Effects Most GLP-1 side effects fade as the body adjusts, typically within four to eight weeks of consistent use
In the SUSTAIN clinical trial program evaluating subcutaneous semaglutide for type 2 diabetes, once-weekly dosing (0.5 mg or 1.0 mg) reduced HbA1c by 1.5% to 1.8% from baseline, with superior glycemic control compared to specific comparators in head-to-head trials (SUSTAIN-7 vs dulaglutide
Works cited GLP-1 Analogues Market Size & Growth Forecast to 2033 MarketsandMarkets, accessed February 2, 2026, GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market Global Forecast to 2033: With the Semaglutide Patent Expiring in 2026 Onwards, the Biosimilars Market is Expected to Grow Significantly GlobeNewswire, accessed February 2, 2026, GLP-1 Receptor Agonists and Patent Strategy: Securing Patent , accessed February 2, 2026, Are GLP-1s about to dethrone oncology as pharmas biggest segment
Cardiol Res Pract 2021:111